NEW YORK, March 27, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on MDT, NVCN, RMD, and WMGI which can be accessed for free by signing up to www.wallstequities.com/registration. On Monday, the NASDAQ Composite ended the day at 7,220.54, up 3.26%; the Dow Jones Industrial Average edged 2.84% higher, to finish at 24,202.60; and the S&P 500 closed at 2,658.55, gaining 2.72%. Gains were broad based as all sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Medical Appliances & Equipment stocks: Medtronic PLC (NYSE: MDT), Neovasc Inc. (NASDAQ: NVCN), ResMed Inc. (NYSE: RMD), and Wright Medical Group N.V. (NASDAQ: WMGI). All you have to do is sign up today for this free limited time offer by clicking the link below.
Dublin, Ireland headquartered Medtronic PLC's stock finished Monday's session 2.50% higher at $78.46 with a total trading volume of 6.16 million shares, which was higher than their three months average volume of 5.45 million shares. The Company's shares are trading below their 50-day moving average by 4.86%. Moreover, shares of Medtronic, which manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide, have a Relative Strength Index (RSI) of 39.05. Get the full research report on MDT for free by clicking below at:
Shares in Richmond, Canada headquartered Neovasc Inc. rose 2.63%, ending yesterday's session at $0.11 with a total trading volume of 39.81 million shares, which was higher than their three months average volume of 16.82 million shares. The Company's shares are trading below their 50-day moving average by 66.61%. Moreover, shares of Neovasc, which develops, manufactures, and markets cardiovascular products worldwide, have an RSI of 26.14. Gain free access to the research report on NVCN at:
On Monday, San Diego, California headquartered ResMed Inc.'s stock saw a rise of 2.93%, to close the day at $98.27. A total volume of 413,154 shares was traded. The Company's shares have advanced 15.64% in the previous three months and 37.31% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 3.12% and 17.69%, respectively. Additionally, shares of ResMed, which develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases, have an RSI of 52.47. Register for your free report coverage on RMD at:
Wright Medical Group
Shares in Amsterdam, the Netherlands headquartered Wright Medical Group N.V. ended the day 1.92% higher at $19.64. A total volume of 827,823 shares was traded. The Company's shares are trading below their 50-day moving average by 7.70%. Furthermore, shares of Wright Medical, which designs, manufactures, markets, and sells extremities and biologics products worldwide, have an RSI of 37.60.
On February 28th, 2018, research firm Barclays reiterated its 'Overweight' rating on the Company's stock with a decrease of the target price from $27 a share to $25 a share. Get the free research report on WMGI at:
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities